文献速递心胸血管麻醉

心脏手术中苯二氮䓬类药物使用模式的多中心分析

Multicentre analysis of practice patterns regarding benzodiazepine use in cardiac surgery.
PubMed 文献 · Br J Anaesth · 2022-01-29

剂量变异的54.7%归因于机构,14.7%归因于主治麻醉医生,30.5%归因于患者因素,提示需更多证据指导个体化用药。

要点

  • 心脏手术中苯二氮䓬类使用普遍,88.5%患者接受,中位咪达唑仑等效剂量4.0 mg。
  • 用药剂量变异主要来自机构(54.7%)和主治麻醉医生(14.7%)。
  • 高龄、大学附属医院、较近手术年份和低医生病例量与用药可能性降低相关。

核心结论

  • 心脏手术中苯二氮䓬类用药变异的约三分之二与机构和主治麻醉医生相关,需严谨研究指导循证个体化用药。

主要发现

  • 剂量变异中54.7%归因于机构,14.7%归因于主治麻醉医生,30.5%归因于患者因素。
  • 两名相似患者接受苯二氮䓬类的调整中位比值比在随机两名医生间为2.68,随机两家机构间为4.19。
  • 与用药可能性降低相关的因素包括年龄>80岁对比≤50岁(调整OR=0.04;95%CI 0.04-0.05)、大学附属医院(0.08,0.02-0.35)、较近手术年份(0.42,0.37-0.49)和低医生病例量(0.44,0.25-0.75)。
  • 与用药可能性增加相关的因素包括体外循环(2.26,1.99-2.55)和药物使用史(1.29,1.02-1.65)。

临床怎么用

  • 麻醉科医生应认识到心脏手术中苯二氮䓬类使用存在显著机构和医生间差异,需结合患者因素审慎决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is controversy regarding optimal use of benzodiazepines during cardiac surgery, and it is unknown whether and to what extent there is variation in practice. We sought to describe benzodiazepine use and sources of variation during cardiac surgeries across patients, clinicians, and institutions. METHODS: We conducted an analysis of adult cardiac surgeries across a multicentre consortium of USA academic and private hospitals from 2014 to 2019. The primary outcome was administration of a benzodiazepine from 2 h before anaesthesia start until anaesthesia end. Institutional-, clinician-, and patient-level variables were analysed via multilevel mixed-effects models. RESULTS: Of 65 508 patients cared for by 825 anaesthesiology attending clinicians (consultants) at 33 institutions, 58 004 patients (88.5%) received benzodiazepines with a median midazolam-equivalent dose of 4.0 mg (inter-quartile range [IQR], 2.0-6.0 mg). Variation in benzodiazepine dosage administration was 54.7% attributable to institution, 14.7% to primary attending anaesthesiology clinician, and 30.5% to patient factors. The adjusted median odds ratio for two similar patients receiving a benzodiazepine was 2.68 between two randomly selected clinicians and 4.19 between two randomly selected institutions. Factors strongly associated (adjusted odds ratio, <0.75, or >1.25) with significantly decreased likelihoods of benzodiazepine administration included older age (>80 vs ≤50 yr; adjusted odds ratio=0.04; 95% CI, 0.04-0.05), university affiliation (0.08, 0.02-0.35), recent year of surgery (0.42, 0.37-0.49), and low clinician case volume (0.44, 0.25-0.75). Factors strongly associated with significantly increased likelihoods of benzodiazepine administration included cardiopulmonary bypass (2.26, 1.99-2.55), and drug use history (1.29, 1.02-1.65). CONCLUSIONS: Two-thirds of the variation in benzodiazepine administration during cardiac surgery are associated with institutions and attending anaesthesiology clinicians (consultants). These data, showing wide variations in administration, suggest that rigorous research is needed to guide evidence-based and patient-centred benzodiazepine administration.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Janda AM, Spence J, Dubovoy T, et al. Multicentre analysis of practice patterns regarding benzodiazepine use in cardiac surgery. Br J Anaesth. 2022. PMID: 35101244. doi:10.1016/j.bja.2021.11.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。